Earnings call transcript: AbbVie Q4 2024 beats expectations, stock surges
AbbVie Inc . (NYSE:ABBV) delivered strong financial results for Q4 2024, surpassing analysts' expectations with an earnings per share (EPS) of $2.16, compared to the forecast of $2.06. The company ...
Hosted on MSN52m
AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today
Shares of AbbVie (NYSE:ABBV) are surging 7% this morning after the pharmaceutical giant reported solid fourth quarter ...
AbbVie swings to Q4 loss amid Cerevel impact; sets in-line guidance
AbbVie (ABBV) stock gains as company sets 2025 earnings outlook in line with expectations after Q4 revenue beat and despite quarterly loss. Read more here.